Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.50 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.50 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.50 |
| ▸ | HTR2B | P41595 | 1/20 | 0.50 |
| ▸ | HTR2A | P28223 | 1/20 | 0.46 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | ESR1 | P03372 | 1/20 | 0.42 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29087264 | 0.91 | HTR2A (0.51) | LMNATRPA1CHRM1SLC6A2ADRA1A | |
| SCHEMBL465786 | 0.87 | HTR2A (0.47) | LMNATRPA1CHRM1SLC6A2ADRA1A | |
| SCHEMBL11185126 | 0.85 | ACHE (0.47) | LMNATRPA1CHRM1SLC6A2ADRA1A | |
| SCHEMBL15719318 | 0.83 | HTR2A (0.44) | LMNATRPA1CHRM1SLC6A2ADRA1A | |
| SCHEMBL29640497 | 0.82 | LMNA (0.54) | LMNATRPA1CHRM1SLC6A2ADRA1A | |
| SCHEMBL11043528 | 0.82 | LMNA (0.54) | LMNATRPA1CHRM1SLC6A2ADRA1A | |
| SCHEMBL11172926 | 0.79 | TDP1 (0.51) | LMNAALDH1A1TDP1SMN1; SMN2KDM4E | |
| SCHEMBL6150468 | 0.79 | KMT2A (0.48) | LMNASLC6A2SLC6A4TDP1TSHR | |
| SCHEMBL6061211 | 0.77 | HTR2A (0.50) | LMNASLC6A2HTR2BHTR2ASLC6A4 | |
| SCHEMBL9715457 | 0.77 | MEN1 (0.46) | HTR2ASLC6A4KCNH2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2003002081-A1 | COMPOSITION COMPRISING A HYDROXYDIPHENYL ETHER DERIVATIVE INHIBITING THE DEVELOPMENT OF BODY ODOURS | L'OREAL (FR) | 2003-01-09 | — | — | WO | claimed |
| WO-2003002080-A1 | COMPOSITIONS CONTAINING A DERIVATIVE OF HYDROXYDIPHENYL ETHER INHIBITING THE DEVELOPMENT OF BODY ODOURS | L'OREAL (FR) | 2003-01-09 | — | — | WO | claimed |
| WO-2003002078-A1 | COMPOSITIONS CONTAINING A HYDROXYDIPHENYL ETHER DERIVATIVE INHIBITING BODY ODOURS | L'OREAL (FR) | 2003-01-09 | — | — | WO | claimed |
| WO-2003002079-A1 | COMPOSITIONS CONTAINING A HYDROXYDIPHENYL ETHER DERIVATIVE INHIBITING BODY ODOURS | L'OREAL (FR) | 2003-01-09 | — | — | WO | claimed |
| WO-2003002072-A1 | COMPOSITIONS CONTAINING A HYDROXYDIPHENYL ETHER DERIVATIVE INHIBITING BODY ODOURS | L'ORÉAL (FR) | 2003-01-09 | — | — | WO | claimed |
| US-20050203179-A1 | Especially suitable for inhibiting the development of body odour in men | CIBA SPECIALTY CHEMICALS CORP. | 2005-09-15 | — | — | US | disclosed |
| EP-1494640-A1 | USE OF HYDROXYDIPHENYL ETHER DERIVATIVES AS ARYLSULFATASE- INHIBITORS IN DEODORANTS AND ANTIPERSPIRANTS | Ciba SC Holding AG (CH) | 2005-01-12 | — | — | EP | disclosed |
| WO-2003086338-A1 | USE OF HYDROXYDIPHENYL ETHER DERIVATIVES AS ARYLSULFATASE- INHIBITORS IN DEODORANTS AND ANTIPERSPIRANTS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2003-10-23 | — | — | WO | disclosed |
| WO-2003002081-A1 | COMPOSITION COMPRISING A HYDROXYDIPHENYL ETHER DERIVATIVE INHIBITING THE DEVELOPMENT OF BODY ODOURS | L'OREAL (FR) | 2003-01-09 | — | — | WO | disclosed |
| WO-2003002080-A1 | COMPOSITIONS CONTAINING A DERIVATIVE OF HYDROXYDIPHENYL ETHER INHIBITING THE DEVELOPMENT OF BODY ODOURS | L'OREAL (FR) | 2003-01-09 | — | — | WO | disclosed |
| WO-2003002078-A1 | COMPOSITIONS CONTAINING A HYDROXYDIPHENYL ETHER DERIVATIVE INHIBITING BODY ODOURS | L'OREAL (FR) | 2003-01-09 | — | — | WO | disclosed |
| WO-2003002072-A1 | COMPOSITIONS CONTAINING A HYDROXYDIPHENYL ETHER DERIVATIVE INHIBITING BODY ODOURS | L'ORÉAL (FR) | 2003-01-09 | — | — | WO | disclosed |
| WO-2003002079-A1 | COMPOSITIONS CONTAINING A HYDROXYDIPHENYL ETHER DERIVATIVE INHIBITING BODY ODOURS | L'OREAL (FR) | 2003-01-09 | — | — | WO | disclosed |
| US-4391995-A | 4-Phenoxy-phenoxy-alkane-carboxylic acid derivatives and process for their manufacture | HOECHST AKTIENGESELLSCHAFT (DE) | 1983-07-05 | — | — | US | disclosed |
| US-4301295-A | ANTILIPEMIC AND ANTICHOLESTEROL AGENTS | HOECHST AKTIENGESELLSCHAFT (DE) | 1981-11-17 | — | — | US | disclosed |
| US-4254262-A | IN THE PRESENCE OF A QUATERNARY AMMONIUM OR PHOSPHONIUM SALT | IHARA CHEMICAL INDUSTRY CO., LTD. (JP) | 1981-03-03 | — | — | US | disclosed |
| US-4238626-A | ANTICHOLESTEROL AND ANTILIPEMIC AGENTS | HOECHST AKTIENGESELLSCHAFT (DE) | 1980-12-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050203179-A1 | Especially suitable for inhibiting the development of body odour in men | SRD5A1, SRD5A2, PON1 | LMNA 4816/4885TRPA1 639/4885CHRM1 2161/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.